ALX Oncology Holdings Inc. (ALXO)
NASDAQ·Healthcare·Biotechnology
$1.19
+8.18%
Mkt Cap $152.10M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
Implied Upside
+1404.2%
Consensus $17.90 vs current $1.19
NASDAQ·Healthcare·Biotechnology
$1.19
+8.18%
Mkt Cap $152.10M
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
+1404.2%
Consensus $17.90 vs current $1.19